Literature DB >> 25379952

Trazodone and cognitive performance in Alzheimer disease.

Einstein Francisco Camargos1, Juliana Lima Quintas, Luciana Lilian Louzada, Janeth O S Naves, Audrey C T Furioso, Otávio Toledo Nóbrega.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25379952     DOI: 10.1097/JCP.0000000000000237

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  6 in total

Review 1.  Therapy for Insomnia and Circadian Rhythm Disorder in Alzheimer Disease.

Authors:  Luigi Ferini-Strambi; Andrea Galbiati; Francesca Casoni; Maria Salsone
Journal:  Curr Treat Options Neurol       Date:  2020-02-05       Impact factor: 3.598

Review 2.  Pharmacotherapies for sleep disturbances in dementia.

Authors:  Jenny McCleery; Daniel A Cohen; Ann L Sharpley
Journal:  Cochrane Database Syst Rev       Date:  2016-11-16

3.  Pharmacotherapies for sleep disturbances in dementia.

Authors:  Jenny McCleery; Ann L Sharpley
Journal:  Cochrane Database Syst Rev       Date:  2020-11-15

4.  Trazodone use and risk of dementia: A population-based cohort study.

Authors:  Ruth Brauer; Wallis C Y Lau; Joseph F Hayes; Kenneth K C Man; David P J Osborn; Robert Howard; Joseph Kim; Ian C K Wong
Journal:  PLoS Med       Date:  2019-02-05       Impact factor: 11.069

5.  Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers.

Authors:  Alice L La; Christine M Walsh; Thomas C Neylan; Keith A Vossel; Kristine Yaffe; Andrew D Krystal; Bruce L Miller; Elissaios Karageorgiou
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

6.  Improved Sleep, Memory, and Cellular Pathological Features of Tauopathy, Including the NLRP3 Inflammasome, after Chronic Administration of Trazodone in rTg4510 Mice.

Authors:  Paula de Oliveira; Claire Cella; Nicolas Locker; Kiran K G Ravindran; Agampodi Mendis; Keith Wafford; Gary Gilmour; Derk-Jan Dijk; Raphaelle Winsky-Sommerer
Journal:  J Neurosci       Date:  2022-03-10       Impact factor: 6.709

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.